VEGFA and neoplasm: In a recent preclinical mouse tumor model mimicking postsurgical adjuvant or metastatic therapy, a VEGF pathway-targeting antibody drug (bevacizumab) with chemotherapy (paclitaxel) resulted in antitumor activity in a metastatic setting [72].